Acrivastine / pseudoephedrine Side Effects
Medically reviewed by Drugs.com. Last updated on May 9, 2022.
Applies to acrivastine/pseudoephedrine: oral capsule
Nervous system
Very common (10% or more): Headache (19%), somnolence (12%)
Common (1% to 10%): Dizziness[Ref]
Gastrointestinal
Common (1% to 10%): Dry mouth, nausea, dyspepsia[Ref]
Hypersensitivity
Postmarketing reports: Serious hypersensitivity reactions (anaphylaxis, angioedema, bronchospasm, erythema multiforme)[Ref]
Psychiatric
Common (1% to 10%): Insomnia, nervousness
Genitourinary
Common (1% to 10%): Dysmenorrhea
Respiratory
Common (1% to 10%): Pharyngitis, cough increase
Other
Common (1% to 10%): Asthenia
More about acrivastine / pseudoephedrine
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (11)
- Drug class: upper respiratory combinations
Patient resources
- Other brands
- Semprex-D
Related treatment guides
References
1. "Product Information. Semprex-D (acrivastine-pseudoephedrine)." Endo Laboratories LLC (2001):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.